Skip to content
ChickenStockChickenStock
Research317450
Myungin Pharm logo

Myungin Pharm (317450) stock

KOSPI · Pharmaceuticals

KRW 42,200+0.96%(+400)

As of the Nov 16 regular-session close (Korea)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 16, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

7.58x

P/B

0.76x

P/S

2.15x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Consolidated · Filed Aug 13, 2026KRW 76.1 billionKRW 27.6 billionKRW 24.3 billion—
Q1 2026Consolidated · Filed May 14, 2026KRW 72.1 billionKRW 25.1 billionKRW 22.7 billion—
Q4 2025Consolidated · Filed Mar 25, 2026KRW 72.1 billionKRW 23.7 billionKRW 23.3 billion—
9M 2025Consolidated · Filed Nov 12, 2025KRW 215.2 billionKRW 68.8 billionKRW 58.2 billion+6.9%
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 25, 2026KRW 287.3 billionKRW 92.5 billionKRW 81.4 billion+6.6%
FY2024Consolidated · Filed Mar 25, 2026KRW 269.4 billionKRW 92.8 billionKRW 68.7 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Year-to-date rows are cumulative from the start of the fiscal year.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
0.41%
Of trading value on Nov 13, 2026
Short-sale value
KRW 0
Previous 20-day average 11.71%
Net short position
12,406 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
165,163 shares
As of Nov 13, 2026 · 1.13% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 20260.41%KRW 0
Nov 12, 20264.02%KRW 10 million
Nov 11, 20265.06%KRW 20 million
Nov 10, 20268.18%KRW 50 million
Nov 9, 202620.16%KRW 300 million
Nov 6, 20269.67%KRW 100 million
Nov 5, 202615.41%KRW 200 million
Nov 4, 20265.33%KRW 40 million
Nov 3, 202616.36%KRW 80 million
Nov 2, 202622.09%KRW 70 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Myungin Pharm (317450) stock information

KOSPI

Myungin Pharm (317450) is listed on KOSPI. Its market capitalization is about KRW 616.9 billion. On trailing-twelve-month earnings the P/E ratio is 7.58, and the P/B ratio is 0.76. Return on equity is 10%. These figures are computed in-house from official filings and are reference information only.

Myungin Pharm — frequently asked questions

What is the P/E ratio of Myungin Pharm (317450)?
On a trailing-twelve-month basis, 317450 trades at a P/E ratio of 7.58. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Myungin Pharm?
317450 has a market capitalization of about KRW 616.9 billion. The figure moves with the share price and is refreshed each trading day.
Does Myungin Pharm pay a dividend?
317450 has a dividend yield of about 4.73%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.